Skip to main content

Table 5 Coagulation function and anticoagulant use

From: Exploring the efficacy of recombinant human pro-urokinase in catheter-directed thrombolysis for acute lower extremity deep venous thrombosis patients

Parameter

Observation Group (n = 43)

Control Group (n = 42)

χ2/Z

P-value

PT (s)

14.25 ± 2.28

12.63 ± 2.45

3.164

0.002

APTT (s)

43.27 ± 4.54

40.12 ± 4.11

3.349

0.001

Fg (g/L)

2.11 ± 0.81

2.81 ± 0.79

4.045

< 0.001

LMWH Duration (days)

7.2 ± 1.5

8.1 ± 1.8

-2.271

0.023

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us